This is a demo store. No orders will be fulfilled.
USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Life Sciences
Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas
The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.
Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.
The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.
We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.
We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.
-
30 Jun 2017 | Europe | Mega Trends
Growth Opportunities in the Western European Oncology Diagnostics Market, Forecast to 2021
Data-driven Solutions and Co-development are Key Growth Drivers
The Western European Oncology Diagnostics Market, Forecast to 2021 study presents an overview of the oncology diagnostics market landscape in the Western European countries, with a focus on EU 5. The analysis provides forecasts for the EU 5 markets, segmented by types of cancer, which include breast cancer, ovarian cancer, cervical cancer, prostate...
$4,950.00 -
23 Jun 2017 | Europe | Market Research
Growth Opportunities in the Western European IVD Industry, Forecast to 2021
Increased R&D Investments and M&As Propel the Growth of Mobile POCT and Clinical Genomics Solutions
Despite global economic and industry challenges, in-vitro diagnostics (IVD) markets continue to grow, mainly due to fast-growing segments like molecular diagnostics, point-of-care testing (POCT), and tissue diagnostics.. A few market dynamics are either positively or negatively affecting certain specific segments in the IVD space; for example, the ...
$4,950.00 -
31 May 2017 | Europe | Mega Trends
Growth Opportunities in the European Next-generation Sequencing Informatics Market, Forecast to 2021
Big-data-driven Clinical Interpretation in Novel Areas is Set to Drive Market Growth
The cost of genomic sequencing has significantly declined in the recent past with the utilization of high-throughput sequencers creating opportunities for Next-generation Sequencing (NGS) informatics to develop genetic insights from the growing volume of sequencing data. As NGS technologies mature and the market stakeholders develop clarity on indu...
$4,950.00 -
29 Mar 2017 | Europe | Mega Trends
Biosimilars Market, Europe, Forecast to 2025
A Growing Number of Incentive Policies to Propel Growth in the Next 5–7 Years, with Oncology as the Fastest Adopter
Patent expiration and increased use of traditional generic drugs are leading to a shift of focus in the pharmaceutical industry toward investment in specialty drugs and high growth areas such as biosimilars. Expensive biopharmaceuticals are largely used for life-saving disorders such as cancer and diabetes, the incidence of which is increasing with...
$4,950.00 -
02 Feb 2017 | Europe | Mega Trends
European Next-generation Sequencing Services Market, Forecast to 2023
Exome and RNA Sequencing Focusing on Applied Markets to Drive Growth
The study aims to analyse the key disruptions transforming the next-generation sequencing (NGS) services market in Europe and profile regional markets with significant growth potential Research Scope: • Revenue Forecasts • Regional Market Dynamics • Market Share Analysis and Top Countries • Key Trends and Growth Opportunities • Game-chan...
$4,950.00 -
17 Jan 2017 | Europe | Market Research
Game-changing Strategies of European Pharma Companies
Strong Focus on Digital Footprint and Beyond-the-pill Services Propel Companies to Innovate and Stay on the Growth Trajectory
Frost & Sullivan has recently completed a comprehensive analysis on the current and future strategic imperatives of game-changing European pharmaceutical companies. The analysis primarily focuses on the changing trends in the pharmaceutical industry with respect to drug research and development, manufacturing, supply chain, and marketing. The study...
$1,500.00 -
24 Dec 2015 | Europe | Market Research
Analysis of the Western European Clinical Laboratories Market
Public Hospital Service Outsourcing to Drive the Growth of Independent Reference Labs
Laboratory consolidations and outsourcing of services are providing more opportunities to the clinical labs. How the market is going to shape up and how the laboratory services structure is transforming in Western Europe is analyzed in this research service. The study provides market overview, market engineering measurements and revenue forecasts, ...
$6,000.00 -
22 Dec 2015 | Europe | Market Research
Healthcare Services Market Outlook for Eastern Europe
Country-level Analysis of Healthcare Systems and Private Hospital Markets
This research service provides an overview of the healthcare systems of selected countries and a competitive analysis of their private hospital markets. The study includes data and analyses on each countrys economic, demographic, and epidemic conditions, the healthcare system and reforms, healthcare expenditure and fund flow system, healthcare infr...
$4,950.00 -
30 Sep 2015 | Europe | Market Research
Profiling the Top Mergers and Acquisition Within Medical Devices Space
Changing Healthcare Dynamics Driving the M&A
The landscape of healthcare is rapidly changing worldwide as governments are reducing healthcare spending through means such as reimbursement cuts. The medical devices market bears the direct brunt of these measures. To overcome this, medical device companies are involved in active mergers and acquisitions (M&A). The study analyses the key factors ...
$1,500.00 -
30 Sep 2015 | Europe | Technology Research
Advanced mechanisms in drug delivery
Impact and assessment of modern mechanisms in drug delivery systems
The research service aims to give a global outlook of the companion diagnostic market landscape, with a specific focus on Western European countries. The segments related to oncology discussed in this study include breast cancer, lung cancer, colorectal cancer and other cancers, and non-oncology related infectious disease, CNS, and cardiovascular. ...
$4,950.00
